Hanmi Pharm (Korea) Today
| 128940 Stock | 257,500 3,000 1.18% |
PerformanceVery Weak
| Odds Of DistressLow
|
Hanmi Pharm is trading at 257500.00 as of the 7th of February 2025, a 1.18 percent increase since the beginning of the trading day. The stock's open price was 254500.0. Hanmi Pharm has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 8th of January 2025 and ending today, the 7th of February 2025. Click here to learn more.
Moving against Hanmi Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Hanmi Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Hanmi Pharm's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Hanmi Pharm or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Hanmi Pharm Co (128940) is traded on Korea Stock Exchange in Korea and employs 2,121 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 3.41 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hanmi Pharm's market, we take the total number of its shares issued and multiply it by Hanmi Pharm's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Hanmi Pharm operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 12.48 M outstanding shares.
Hanmi Pharm generates positive cash flow from operations, but has no cash available
Check Hanmi Pharm Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Hanmi Pharm is USD3.41 Trillion. Hanmi Pharm secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Hanmi Ownership Details
Hanmi Pharm Risk Profiles
Although Hanmi Pharm's alpha and beta are two of the key measurements used to evaluate Hanmi Pharm's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.75 | |||
| Standard Deviation | 2.47 | |||
| Variance | 6.08 | |||
| Risk Adjusted Performance | (0.15) |
Hanmi Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Hanmi Pharm without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
| All Next | Launch Module |
Hanmi Pharm Corporate Management
Elected by the shareholders, the Hanmi Pharm's board of directors comprises two types of representatives: Hanmi Pharm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hanmi. The board's role is to monitor Hanmi Pharm's management team and ensure that shareholders' interests are well served. Hanmi Pharm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hanmi Pharm's outside directors are responsible for providing unbiased perspectives on the board's policies.
| GwanSun Lee | Exec Strategy | Profile | |
| JongSoo Woo | Pres CEO | Profile | |
| MaengSub Kim | Head Director | Profile | |
| MoonKyee Ju | Managing Director | Profile | |
| JongWoo Park | Managing Director | Profile | |
| JongHo Lim | CSR Director | Profile | |
| JuHyun Lim | Managing Director | Profile |
Other Information on Investing in Hanmi Stock
Hanmi Pharm financial ratios help investors to determine whether Hanmi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hanmi with respect to the benefits of owning Hanmi Pharm security.